The best indicator for Johnson & Johnson (JNJ)
We backtested 366 indicators across daily, weekly and hourly charts on real Johnson & Johnson (JNJ) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Markov Regime
On the weekly chart, this is the strongest risk-adjusted edge we found for Johnson & Johnson (JNJ) over ~64.7 years — trailing buy-and-hold by 0.4% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Johnson & Johnson (JNJ) — trailing buy-and-hold by 8.8% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Markov Regime ✓ | Weekly | 13.3% | 0.7 | -50.7% | 63.9% | 72 | -0.4% |
| 2 | Trend Intensity Index ✓ | Weekly | 12.1% | 0.69 | -38.2% | 81.2% | 16 | -1.6% |
| 3 | SMA 20/80 Cross ✓ | Weekly | 11.9% | 0.68 | -36.4% | 82.4% | 17 | -1.8% |
| 4 | VIDYA 200 Trend ✓ | Daily | 12.8% | 0.66 | -57.2% | 25.0% | 32 | -0.9% |
| 5 | SMA 20/50 Cross ✓ | Weekly | 11.2% | 0.66 | -41.8% | 63.3% | 30 | -2.5% |
| 6 | EMA 20/80 Cross ✓ | Weekly | 11.6% | 0.66 | -47.2% | 62.5% | 16 | -2.1% |
| 7 | Markov Regime ✓ | Daily | 12.0% | 0.64 | -64.7% | 48.9% | 141 | -1.7% |
| 8 | QQE ✓ | Weekly | 11.5% | 0.63 | -62.1% | 53.1% | 194 | -2.2% |
| 9 | ROC (60) ✓ | Weekly | 10.5% | 0.62 | -59.8% | 47.9% | 71 | -3.2% |
| 10 | Vegas Tunnel ✓ | Weekly | 10.3% | 0.61 | -44.4% | 51.0% | 49 | -3.4% |
| 11 | EMA 200 Trend ✓ | Weekly | 10.5% | 0.61 | -49.3% | 40.0% | 40 | -3.2% |
| 12 | EMA 8/21 Cross ✓ | Weekly | 9.5% | 0.6 | -50.7% | 50.8% | 63 | -4.2% |
| 13 | Stochastic RSI ✓ | Weekly | 6.7% | 0.6 | -25.8% | 75.7% | 103 | -7.0% |
| 14 | Volume Flow Indicator ✓ | Weekly | 9.9% | 0.6 | -42.8% | 50.0% | 24 | -3.8% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Johnson & Johnson (JNJ), Markov Regime on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.